Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aurora Biosciences (ABSC) -- Ignore unavailable to you. Want to Upgrade?

To: Larry Liebman who wrote (238)	12/20/1999 11:11:00 AM
From: biowa	Read Replies (1) \| Respond to of 359

Larry, Am I missing something with stock at $11 7/8? Someone more devoted to ABSC should feel free to trump, debunk, correct and otherwise say this is wrong. No, you're probably not missing something. Three points to consider, though: There a lots of biotech and tool companies undervalued right now - despite the run-ups in some momo sectors such as genomics and mAbs. While ABSC reminds of MLNM, it could also remind of the combi chem companies. That would yield completely different expectations, and I believe at least some are waiting to see which direction the business model leads. Part of what has made genomics HOT, HOT, HOT isn't just the science, its the convergence of management teams like Levin/Holtzman, et al at MLNM, INCY's folks, and even (grrr!) Haseltine at HGSI with the science. There are several other genomics companies which until the recent momo couldn't buy respect. Even if the ABSC team is in that class, it'll take time for the market to recognize that. FWIW, biowa